← Eichor
Condition: Human Immunodeficiency Virus Type 1 Hiv 1 Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Human Immunodeficiency Virus Type 1 Hiv 1 Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
NA · 3 location(s) · bioLytical Laboratories · NCT07563309Impacts of HIV Treatment Regimens on Archived Drug Resistance
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07643948A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi
Phase 1 · 6 location(s) · BioNTech SE · NCT07392372PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY
NA · 2 location(s) · Centre for Infectious Disease Research in Zambia · NCT07021092Analyses of Newly Diagnosed HIV Infection in Hong Kong
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07725042A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Phase 3 · 30 location(s) · Merck Sharp & Dohme LLC · NCT07071623Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Imm
Phase 1/Phase 2 · 1 location(s) · Jiangsu Aidea Pharmaceutical Group Co., Ltd. · NCT07711223REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Phase 4 · 10 location(s) · CAN Community Health · NCT07476339Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
Phase N/A · 7 location(s) · Pomeranian Medical University Szczecin · NCT07370649Prevention ICONA Dedicated Ensemble
Phase N/A · 53 location(s) · Fondazione ICONA · NCT07186244A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan
NA · 1 location(s) · Massachusetts General Hospital · NCT06566430A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · 55 location(s) · Merck Sharp & Dohme LLC · NCT07266831Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal o
NA · 5 location(s) · Centre Hospitalier Régional d'Orléans · NCT06834113Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
NA · 2 location(s) · Desmond Tutu HIV Foundation · NCT05602376Safety Study of MucoCept-CVN
Phase 1 · 1 location(s) · Craig Cohen, MD, MPH · NCT07181486
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.